Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-23

Clinical Trial Update: A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting results for duloxetine in participants with chronic low back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Back Pain Lower Back Chronic | Phase 3 | Status: COMPLETED | Results posted: 2015-07-23